These data demonstrated that GJB2 regulated the development of pancreatic cancer by inhibiting cellular apoptosis, promoting cellular proliferation, and altering cellular differentiation through the enriched KEGG pathways. This evidence concerns the gene GJB2 and pancreatic neoplasm.